Oura Health has raised $1.3B across 3 funding rounds, plus 5 undated rounds. The latest round valued Oura Health at $11B post-money, with Fidelity Management on the lead line.
Oura raised an initial $2.3 million seed round in 2015 led by Lifeline Ventures. A 2024 Series D of $200 million backed by Fidelity Management and Dexcom valued the company at about $5.2 billion, and in October 2025 Oura raised a further $900 million Series E.
3 funding rounds, the latest highlighted.
Oura Health was founded in 2013, United States.
No date is disclosed for this round.
Invited institutions. $100M raised, led by The Chernin Group, Elysian Park Ventures, Temasek, JAZZ Venture Partners, Eisai.
Existing holders. $200M raised.
Invited institutions. $900M raised, led by Fidelity Management.
A filing has been made.
3 dated rounds, newest first.
DexcomLEADMMSD CapitalLEADBBold Capital PartnersLEADTTesiLEADJJoi ItoLEADJJaan TallinnLEAD
Lifeline VenturesLEADFFidelity ManagementLEADTThe Chernin GroupLEADEElysian Park VenturesLEAD
TemasekLEADJJAZZ Venture PartnersLEADEEisaiLEADIICONIQAAtreidesWWhale RockEElysian ParkLead investors for each round are in the funding timeline.
The closest wearable health technology (smart ring) peers are on the competitors page.
Current status: filed.
The routes section explains what is realistically available for a company at this stage.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
